| South Valley Care Center, Llc | |
| 1629 Bowe Lane Sw, Albuquerque, New Mexico 87105 | |
| (505) 877-2200 | |
| Name | South Valley Care Center, Llc |
|---|---|
| Location | 1629 Bowe Lane Sw, Albuquerque, New Mexico |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 62 |
| Occupancy Rate | 85% |
| Medicare ID (CCN) | 325083 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | For Profit - Individual |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In 2005, then 40-year-old Walt McGuire was playing hockey twice a week, working full-time and chasing his young daughter. Then one day, he noticed after one trip up the stairs to catch her, he couldn't catch his breath. A few days later his legs were swollen. After numerous trips to different doctors, McGuire finally was diagnosed with a rare blood disorder called amyloidosis.
Complications following COVID-19 infection require quick identification and management to help plan policy and health system responses. Researchers in the UK recently described the 12-month experience of the first dedicated post-COVID clinical service in the UK to include both hospitalized and non-hospitalized COVID-19 patients. This study has been released on the medRxiv* the preprint server.
To learn what different cells do, scientists switch them on and off and observe what the effects are. There are many methods that do this, but they all have problems: too invasive, or too slow, or not precise enough. Now, a new method to control the activity of neurons in mice, devised by scientists at Rockefeller University and Rensselaer Polytechnic Institute, avoids these downfalls by using magnetic forces to remotely control the flow of ions into specifically targeted cells.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming investment conferences.
BD, a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.73 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.56 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.76 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.49 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.39 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.05 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.26 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.45 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 8.47 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.22 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.17 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 47.89 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 0 | 82.93 |
News Archive
In 2005, then 40-year-old Walt McGuire was playing hockey twice a week, working full-time and chasing his young daughter. Then one day, he noticed after one trip up the stairs to catch her, he couldn't catch his breath. A few days later his legs were swollen. After numerous trips to different doctors, McGuire finally was diagnosed with a rare blood disorder called amyloidosis.
Complications following COVID-19 infection require quick identification and management to help plan policy and health system responses. Researchers in the UK recently described the 12-month experience of the first dedicated post-COVID clinical service in the UK to include both hospitalized and non-hospitalized COVID-19 patients. This study has been released on the medRxiv* the preprint server.
To learn what different cells do, scientists switch them on and off and observe what the effects are. There are many methods that do this, but they all have problems: too invasive, or too slow, or not precise enough. Now, a new method to control the activity of neurons in mice, devised by scientists at Rockefeller University and Rensselaer Polytechnic Institute, avoids these downfalls by using magnetic forces to remotely control the flow of ions into specifically targeted cells.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming investment conferences.
BD, a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.
› Verified 8 days ago
Sandia Ridge Center Location: 2216 Lester Drive Ne, Albuquerque, New Mexico 87112 Phone: (505) 296-4808 | |
The Rehabilitation Center Of Albuquerque Location: 5900 Forest Hills Drive Ne, Albuquerque, New Mexico 87109 Phone: (505) 822-6000 | |
Las Palomas Center Location: 8100 Palomas Avenue Ne, Albuquerque, New Mexico 87109 Phone: (505) 821-4200 | |
Uptown Rehabilitation Center Location: 7900 Constitution Avenue Ne, Albuquerque, New Mexico 87110 Phone: (505) 296-5565 |